Table 3 Basic information of HCV patients in different immune-based clusters
Characteristics | Whole cohort (216) | Immune low (175) | Immune high (41) |
|---|---|---|---|
Survival | 150 (69.44%) | 132 (75.43%) | 18 (43.90%) |
Survival time (days) | 3373.13 ± 1525.10 | 3495.29 ± 1473.06 | 2851.73 ± 1648.90 |
Bilirubin ≥ 1.0 mg/dl | 108 (50.00%) | 84 (48.00%) | 24 (58.54%) |
HCC | 65 (30.09%) | 48 (27.43%) | 17 (41.46%) |